Position in ABBV
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$17,220,228
+$2,394,370 QoQ
Shares Held
68,432
+0.4% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
2.07%
of 13F equity value
Holder Rank
#679
of 4,167 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Fort Sheridan Advisors LLC holds $58,603,256 across 10 Drug Manufacturers - General names. ABBV ranks #1 (29.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
This page
|
68,432 | $17,220,228 | |
| 2 | JNJ |
Johnson & Johnson
|
50,589 | $12,848,088 | |
| 3 | MRK |
Merck & Co., Inc.
|
98,070 | $12,601,995 | |
| 4 | LLY |
ELI LILLY & Co
|
5,314 | $6,373,771 | |
| 5 | AMGN |
Amgen Inc
|
8,505 | $3,079,830 | |
| 6 | PFE |
Pfizer Inc
|
120,987 | $2,913,366 | |
| 7 | NVS |
Novartis AG
|
13,967 | $2,188,908 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
4,810 | $607,695 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $17,220,228 | 68,432 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $14,825,858 | 68,168 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $14,872,642 | 65,091 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $15,022,315 | 64,880 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $12,179,456 | 65,615 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $13,928,680 | 66,479 | Shares | Sole | 2025-05-01 | |
| 2024-12-31 | $11,815,273 | 66,490 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $12,872,338 | 65,183 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $10,921,021 | 63,672 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $8,264,244 | 45,383 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $6,970,860 | 44,982 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $6,359,346 | 42,663 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $5,450,636 | 40,456 | Shares | Sole | 2023-08-01 | |
| 2023-03-31 | $6,034,545 | 37,865 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $3,305,732 | 20,455 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $2,819,349 | 21,007 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $3,138,401 | 20,491 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $3,333,954 | 20,566 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $2,962,416 | 21,879 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $2,333,443 | 21,632 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $2,232,750 | 19,822 | Shares | Sole | 2021-08-17 | |
| 2021-03-31 | $2,001,204 | 18,492 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $1,412,879 | 13,186 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $1,002,292 | 11,443 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $1,120,233 | 11,410 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $860,337 | 11,292 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||